Wave life sciences reports q1 loss per share of $1.38

Wave life sciences reports first quarter 2020 financial results and provides business update.as of march 31, had $120.9 million in cash and cash equivalents.wave life sciences - expects that existing cash and cash equivalents, expected and committed cash will enable co to fund requirements into q3 of 2021.qtrly loss per share $1.38.qtrly revenue $4.2 million versus $3.0 million.q1 earnings per share view $-1.20 -- refinitiv ibes data.
WVE Ratings Summary
WVE Quant Ranking